Am I right in saying with the current programs the bulk of the data should be coming through by end of Q3 2022. Wouldn't this be the timeframe for serious discussions to commence with large Pharma?
Speculative M&A Transaction Analysis, page-666
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
0.260(14.9%) |
Mkt cap ! $342.2M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $2.08 | $1.86 | $1.269M | 645.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 505 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 4543 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |